BS

BSI SA

Europe, Ticino, Switzerland, Lugano

Description

BSI SA provides asset management and related services to private and institutional clients in Switzerland and internationally.

Investor Profile

BSI SA has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (40%)
  • Series E (40%)
  • Series A (20%)

Country Focus

  • United States (80%)
  • Switzerland (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Pharmaceutical
  • Medical
  • Biopharma
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BSI SA frequently co-invest with?

BP
North America, California, United States, San Diego
Co-Investments: 2
Mizuho Securities
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
SV
North America, Texas, United States, Austin
Co-Investments: 2
CC
North America, California, United States, San Francisco
Co-Investments: 2
SL
North America, California, United States, Redwood City
Co-Investments: 2
PL
Europe, Hamburg, Germany, Hamburg
Co-Investments: 2
CS
North America, Georgia, United States, Mcdonough
Co-Investments: 2
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Glynn Capital Management
North America, California, United States, Menlo Park
Co-Investments: 2
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by BSI SA?

VisionCare Ophthalmic Technologies

Saratoga, California, United States

VOT develops visual prosthetic devices to improve vision in patients with end-stage age-related macular degeneration.

Health CareMedicalMedical Device
Series EJan 10, 2011
Amount Raised: $31,000,000
GlobeImmune

Louisville, Colorado, United States

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

BiotechnologyMedicalTherapeutics
Series EJan 19, 2010
Amount Raised: $17,500,000
Telormedix

Bioggio, Ticino, Switzerland

Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ASep 30, 2008
Amount Raised: $19,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DJan 6, 2006
Amount Raised: $50,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DFeb 28, 2005
Amount Raised: $74,000,000